SBC Medical Initiates Development of a DNA Methylation Test to Estimate Biological Age
Business Wire•22/10/2026•09:00 ET
0
Key Highlights
- ➤SBC Medical begins developing a DNA methylation test estimating biological age
- ➤SBC AI Longevity Innovation will lead the test’s in-house development
- ➤Waqoo Group research and technology will support the development initiative
- ➤Roadmap targets organ-specific mapping, non-invasive modalities, and Japan-specific data
- ➤Global longevity market projected to grow from $800 billion in 2025 to $2 trillion by 2035
SBC Medical Initiates Development of a DNA Methylation Test to Estimate Biological Age
Leveraging the Waqoo Group’s research and technology ecosystem to establish a new personal baseline for proactive health and longevity
Get started
Create a free account to read the full story.